Curaleaf Holdings, Inc.
CSE:CURA.CN
5 (CAD) • At close November 17, 2023
Overview | Financials
Numbers are in millions (except for per share data and ratios) CAD.
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 1,336.342 | 1,209.661 | 626.637 | 221.018 | 77.057 | 19.313 | 0 | 0 | 0 |
| Cost of Revenue
| 757.311 | 522.072 | 236.124 | 79.405 | 30.77 | 3.716 | 0 | 0 | 0 |
| Gross Profit
| 579.031 | 687.589 | 390.513 | 141.613 | 46.287 | 15.597 | 0 | 0 | 0 |
| Gross Profit Ratio
| 0.433 | 0.568 | 0.623 | 0.641 | 0.601 | 0.808 | 0 | 0 | 0 |
| Reseach & Development Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0.027 | 0 | 0 |
| General & Administrative Expenses
| 430.946 | 373.897 | 234.881 | 125.441 | 63.277 | 17.39 | 0.091 | 0.159 | 0.045 |
| Selling & Marketing Expenses
| 44.609 | 41.841 | 23.272 | 12.188 | 4.264 | 1.542 | 0 | 0.002 | 0.002 |
| SG&A
| 475.555 | 415.738 | 258.153 | 137.629 | 67.541 | 18.932 | 0.091 | 0.161 | 0.047 |
| Other Expenses
| 115.848 | 96.217 | 68.676 | 31.701 | -25.049 | 0.259 | -0 | 0.001 | 0.001 |
| Operating Expenses
| 591.403 | 511.955 | 326.829 | 169.33 | 74.968 | 22.142 | 0.118 | 0.161 | 0.047 |
| Operating Income
| -10.248 | 175.634 | 63.684 | -21.036 | -28.681 | -6.545 | -0.118 | -0.161 | -0.047 |
| Operating Income Ratio
| -0.008 | 0.145 | 0.102 | -0.095 | -0.372 | -0.339 | 0 | 0 | 0 |
| Total Other Income Expenses Net
| -214.057 | 6.223 | -41.641 | -24.753 | -27.553 | 1.684 | 1.022 | 0.001 | 0.001 |
| Income Before Tax
| -226.429 | 64.796 | 22.043 | -45.789 | -56.234 | -3.976 | -0.118 | -0.161 | -0.046 |
| Income Before Tax Ratio
| -0.169 | 0.054 | 0.035 | -0.207 | -0.73 | -0.206 | 0 | 0 | 0 |
| Income Tax Expense
| 150.502 | 173.926 | 83.371 | 24.059 | 5.643 | 1.068 | 0 | 0 | 0 |
| Net Income
| -376.931 | -109.13 | -61.328 | -69.848 | -56.467 | -2.818 | -0.118 | -0.161 | -0.046 |
| Net Income Ratio
| -0.282 | -0.09 | -0.098 | -0.316 | -0.733 | -0.146 | 0 | 0 | 0 |
| EPS
| -0.53 | -0.16 | -0.11 | -0.15 | -0.14 | -0.009 | -0.1 | -0.2 | -0.062 |
| EPS Diluted
| -0.53 | -0.16 | -0.11 | -0.15 | -0.14 | -0.009 | -0.1 | -0.2 | -0.062 |
| EBITDA
| 166.225 | 179.117 | 160.053 | 16.17 | -12.304 | -1.986 | -1.099 | -0.161 | -0.047 |
| EBITDA Ratio
| 0.124 | 0.256 | 0.255 | 0.073 | -0.523 | 0.022 | 0 | 0 | 0 |